February 2014 – content
Life Sciences
Interscience expands manufacturing facility
BioNano Genomics raises further funds
Izon relocates global headquarters
HBIO cuts worldwide staff numbers
GE to buy life science products lines from Thermo Fisher
GenapSys raises funds to commercialise NGS platform
TTP Labtech acquires fluorescence lifetime assets
DNAnexus wins $15m funding
Tute Genomics wins funds
Instem purchase image analysis company
General Laboratory
Spectro widens focus beyond machine condition monitoring
Anton Paar buys expert in surface properties testing
Artel expands with software acquisition
CSC becomes distributor of viscometer family
Fritsch opens second Chinese office
Mocon opens certified laboratory
Newport wins unnamed OEM customer
Process & hand-held instrumentation
Pall buys in single-use bioprocess business
E+H opens sales operations in Africa and Middle East
Block Engineering in OEM deal for oil & gas
Applikon celebrates anniversary
Market Feature
Recovery predicted on stronger markets in Q3
Financials
Life sciences markets buoyant for instrument firms
Olympus confident after rebound in Japanese LS sector
Acquisitions boost Eurofins
PBI marketing push drives sales
US medical devices tax takes bite out of BD
Luminex hit by order delays
Transgenomic remains in the red
WaferGen raises much-needed capital
Trading conditions improve for lab instrument companies
Shimadzu raises forecast seeing strength in several markets
PerkinElmer back in the black
Horiba benefits from weaker yen and semicon rebound
Acquisition drives Corning
Skyray returns to solid growth
Oxford Instruments sees stronger demand ahead
Accelrys drops to a loss in Q3
Process firms see signs of industrial market rebound
Roper cuts guidance and warns of sluggishness ahead
Eurocontrol turns a profit
Stronger orders give Pall hope of industrial recovery
Weak ETD shipments hit Implant
Olympus up on domestic rebound
SPX benefits from cost cuts
Appointments